Delivery Order 36F79722D0165-36C24526N0497
Award Date 4/9/26
Potential Completion Date 4/14/26
Potential Value $2K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Dublin, OH 43017, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Ardelyx, Inc., a pharmaceutical company based in Fremont, California, was awarded a delivery order for XPHOZAH 30 mg by Veterans Integrated Service Network 5 (VISN 5), a component of the Department of Veterans Affairs. This contract, valued at $2,016.52, represents a firm fixed-price delivery order issued on September 19, 2025, with an ultimate completion date of September 23, 2025. The award is performed under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and will be...
- Otsuka America Pharmaceutical Inc. received a delivery order award valued at $11,413.72 from the Department of Veterans Affairs' Veterans Integrated Service Network 6 (VISN 6) on January 27, 2022, with a completion date of February 28, 2022. The contract, issued under a firm fixed-price arrangement with no set-aside designation, is for medication to be delivered to Potomac, Maryland. This delivery order falls under the parent Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), through...
- The Department of Veterans Affairs, Veterans Integrated Service Network 6, awarded a $10,303.55 firm fixed-price delivery order to Otsuka America Pharmaceutical Inc. for Jynarque 15mg/45mg medication for patient E.W. The award was issued on March 26, 2021, with an ultimate completion date of April 2, 2021. This delivery order was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and does not utilize a set-aside designation. The place of performance is Richmond,...
- The Department of Veterans Affairs, Veterans Integrated Service Network 5 (VISN 5) awarded a delivery order to Madrigal Pharmaceuticals, Inc. for REZDIFFRA 80 mg pharmaceutical products with a ceiling value of $35,623.08. The contract, awarded on April 3, 2026, utilizes a firm fixed-price structure with an ultimate completion date of April 7, 2026. This award is not set-aside and represents a delivery order under the parent Pharmaceuticals and Drugs (FSS-61-IB) General Services Administration...
- This federal contract award is for "EMERGENCY LYMYRZ" and was issued by the Veterans Integrated Service Network 9 (VISN 9), a civilian agency. The contract was awarded to Avadel CNS Pharmaceuticals, LLC, a for-profit, foreign-owned organization, on September 22, 2025 as a Firm Fixed Price Delivery Order with a ceiling value of $11,197.82 and a completion date of September 30, 2025. The contract is not set aside and is under the Pharmaceuticals and Drugs Federal Supply Schedule...
- The Department of Veterans Affairs, Veterans Integrated Service Network 5 (VISN 5), awarded a delivery order valued at $10,034.36 to Otsuka America Pharmaceutical Inc. on April 15, 2020, for pharmaceutical products under the Medication Order Big 4 contract. This firm fixed-price delivery order, with an ultimate completion date of April 30, 2020, was performed in Potomac, Maryland, and did not utilize any set-aside designation. The award falls under the Pharmaceuticals and Drugs Federal Supply...
- Otsuka America Pharmaceutical Inc., a Maryland-based specialty pharmaceutical manufacturer, was awarded a firm fixed price delivery order valued at $12,195.72 by Veterans Integrated Service Network 5 (VISN 5) on October 4, 2023, with an ultimate completion date of October 6, 2023. The contract calls for the delivery of Jynarque (tolvaptan) in 90mg/30mg dosages to support the Department of Veterans Affairs' healthcare operations in Pittsburgh, Pennsylvania. This delivery order operates under...
- Otsuka America Pharmaceutical Inc., a specialty pharmaceutical manufacturer headquartered in Rockville, Maryland, was awarded a delivery order on August 8, 2022, for medication supply to the Department of Veterans Affairs' Veterans Integrated Service Network 6. This firm-fixed price delivery order, valued at $11,413.72 with an ultimate completion date of August 31, 2022, represents a task order under the company's broader Blanket Purchase Agreement for pharmaceuticals issued through the...
- This federal contract award is a firm fixed-price delivery order issued by the U.S. Department of Veterans Affairs (VA) to Acorda Therapeutics, Inc., a biotechnology company that specializes in developing and commercializing therapies for neurological disorders. The contract, valued at $485,835.00, is for the supply of DALFAMPRIDINE 100 MG, a medication used to treat Parkinson's disease and multiple sclerosis symptoms. The contract was awarded on January 17, 2017, with a final completion date of...
- This is a firm fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Acorda Therapeutics, Inc., a biotechnology company specializing in neurological treatments. The contract, valued at $1,436,580.00, is for the supply of Dalfampridine 10mg tablets, a medication used to treat neurological disorders. The contract was awarded under Acorda's existing Federal Supply Schedule (FSS) contract with the VA, FSS-61-IB Pharmaceuticals and Drugs, which has a total ceiling...